Events by Type: Lectures and Panels
When is a Medical Treatment Worth $850,000? The Value of Luxturna and Gene Therapy Treatments: A Health Policy and Bioethics Consortium
Luxturna, a gene therapy treatment for a rare form of inherited blindness, was recently approved and administered for the first time to a patient at Massachusetts Eye and Ear in…
Simulation and Deliberation to Prepare for Clinical Trials in Infectious Disease Emergencies: Digital Health @ Harvard Series
Description Infectious disease emergencies are opportunities to test the efficacy of newly developed interventions (e.g. drugs, vaccines and treatment regimens), yet they raise many intertwined challenges of politics, logistics,…
An MD’s Take on Single-Payer Health Care
The ACA’s passage sparked a national dialogue about what type of health care works best for the United States. Having failed to repeal the ACA, the current administration…
Antibiotic Resistance: What Collaboration and Policy Can Do For Our Future
Description U.S. PIRG and Harvard Law School invite you to a panel discussion about antibiotic resistance as part of Antibiotic Awareness Week. The World Health Organization ranks antibiotic resistance…
Provider Consolidation: Implications for Costs and Quality in Health Care Delivery: A Health Policy and Bioethics Consortium
In the last decade, the traditional conception of individual physicians or medical groups has been increasingly replaced by consolidation under academic medical centers and other national or regional administrative organizations.…
Achieving Equitable Access to Vaccines: From Policies to Provisions
Description In order to achieve the objectives of global health organization policies those policies must be translated into actionable provisions and agreements. The Global Healthcare Innovation Alliance Accelerator endeavors to…
Digital Health @ Harvard Series: Medicaid Work Requirements: Limitations in Digitally Identifying Individuals for Exemption Due to Disability
Description This year, several states applied for and received permission from the federal government to implement work requirements in their Medicaid programs. Policy designs vary by state, but all states…
Ethical Investment in Global Public Health Security: A Health Policy and Bioethics Consortium
Description Health emergencies around the world in recent years have included SARS, MERS, Ebola, and influenza. These epidemics have caused substantial mortality, destabilized governments, and served as significant risks to…
Bad Blood: Secrets and Lies in a Silicon Valley Startup: A Special Evening with Author John Carreyrou
This event featured moderated discussion with John Carreyrou, investigative reporter for the Wall Street Journal and author of the New York Times bestseller Bad Blood: Secrets and Lies in a…
The US Opioid Epidemic: Where Do We Go from Here?: A Health Policy and Bioethics Consortium
Description The US has struggled with an epidemic of prescription opioid overuse and abuse, which has contributed to an uptick in illegal drug use and affected communities across the country.…
2018 Petrie-Flom Center Open House
At this reception, faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics gathered to learn about what the Petrie-Flom Center does and how to get…
Book Launch: Big Data, Health Law, and Bioethics
Couldn't join us for the event? Check out coverage from HLS Today and view some of the panelists' slide presentations below! Description In March 2018, Cambridge University Press published Big…
Sources and Consequences of High Drug Prices in the US: A Health Policy and Bioethics Consortium
Description High drug costs reduce patient adherence and lead to worse outcomes. The process for translating a drug's price, set by the manufacturer, to cost paid by patients and…
How to Fix Youth Sports Concussion Laws: Neuroscientific Perspectives
Couldn't join us for the event? Check out some of the panelists' slide presentations below! Description With growing neuroscientific research on sports concussions, states have revised their policies and…
Health Law in the Private Sector: A Panel Discussion with Law Firm Partners and In-House GCs
Description Please join the Harvard Health Law Society; the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics; and the Office of Career Services at Harvard Law School for a…
Crimes of Passion: New Neuroscience vs. Old Doctrine
Couldn't join us for the event? Check out some of the panelists' slide presentations below! Description The criminal law often sees love and passion turned into violence. How does…
Video Now Available! Health in the Headlines: Reporting on Health Policy in the Trump Era
Couldn't join us in person? Check out the conversation online!: #HealthintheHeadlines @HarvardCHLPI @PetrieFlom @jrovner @sangerkatz @rachanadixit @emma_sandoe Description The Center for Health Law and Policy Innovation hosted this…
Health Law and Public Service
Please join the Harvard Health Law Society; the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics; and the Center for Health Law and Policy Innovation at Harvard Law School…
The Future of the Affordable Care Act Following the Elimination of Cost-Sharing Reduction Payments
Michael Frakes is a Professor of Law at Duke Law School and a faculty research fellow at the National Bureau of Economic Research. He is generally interested in empirical research…
Enabling Disability Rights in the U.S. and around the World
Professor Michael Stein is the co-founder and Executive Director of the Harvard Law School Project on Disability. An internationally acclaimed expert on disability law and policy, Stein participated in the…